Found: 272
Select item for more details and to access through your institution.
CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Recent success and limitations of immune checkpoint inhibitors for cancer: a lesson from melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Complete atrioventricular block in a patient with intracardiac metastases from malignant melanoma.
- Published in:
- European Journal of Echocardiography, 2011, v. 12, n. 8, p. 636
- By:
- Publication type:
- Article
Cost of illness del carcinoma cutaneo a cellule squamose (CSCC).
- Published in:
- Global & Regional Health Technology Assessment, 2020, v. 7, n. 1, p. 148, doi. 10.33393/grhta.2020.2171
- By:
- Publication type:
- Article
Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 5, p. 515, doi. 10.1093/nop/npae038
- By:
- Publication type:
- Article
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09373-9
- By:
- Publication type:
- Article
Imaging Assessment of Interval Metastasis from Melanoma.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 7, p. 1033, doi. 10.3390/jpm12071033
- By:
- Publication type:
- Article
Multiple molecular pathways in melanomagenesis: characterization of therapeutic targets.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00183
- By:
- Publication type:
- Article
Melanoma: from incurable beast to a curable bet. The success of immunotherapy.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00152
- By:
- Publication type:
- Article
Melanoma: from incurable beast to a curable bet. The success of immunotherapy.
- Published in:
- Frontiers in Oncology, 2015, p. 1
- By:
- Publication type:
- Article
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 6, p. 987, doi. 10.1007/s40257-024-00885-w
- By:
- Publication type:
- Article
MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid Tumors.
- Published in:
- American Journal of Clinical Dermatology, 2017, v. 18, n. 6, p. 745, doi. 10.1007/s40257-017-0292-y
- By:
- Publication type:
- Article
Covid‐19: Time for a paradigm change.
- Published in:
- Reviews in Medical Virology, 2020, v. 30, n. 5, p. 1, doi. 10.1002/rmv.2134
- By:
- Publication type:
- Article
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 6, p. 623, doi. 10.1007/s11912-023-01402-8
- By:
- Publication type:
- Article
The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 9, p. N.PAG, doi. 10.1007/s11912-019-0827-x
- By:
- Publication type:
- Article
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4922, doi. 10.3390/ijms24054922
- By:
- Publication type:
- Article
Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 1801, doi. 10.3390/ijms22041801
- By:
- Publication type:
- Article
MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 12, p. 4544, doi. 10.3390/ijms21124544
- By:
- Publication type:
- Article
In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 1930, doi. 10.3390/ijms21061930
- By:
- Publication type:
- Article
A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patients: Preliminary Results.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 1, p. 136, doi. 10.3390/jcm10010136
- By:
- Publication type:
- Article
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2430, doi. 10.3390/jcm9082430
- By:
- Publication type:
- Article
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1577, doi. 10.3390/jcm8101577
- By:
- Publication type:
- Article
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 203, doi. 10.3390/vaccines8020203
- By:
- Publication type:
- Article
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09373-9
- By:
- Publication type:
- Article
A Metabolomics-Based Screening Proposal for Colorectal Cancer.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/metabo12020110
- By:
- Publication type:
- Article
Successful application of chemosaturation with percutaneous hepatic perfusion in metastatic uveal melanoma patient progressing after systemic treatment options: a case report.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1355971
- By:
- Publication type:
- Article
PD-L1<sup>+</sup> neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.962669
- By:
- Publication type:
- Article
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.811131
- By:
- Publication type:
- Article
MDM2 SNP309 and p53 Arg72Pro in cutaneous melanoma: association between SNP309 GG genotype and tumor Breslow thickness.
- Published in:
- Journal of Human Genetics, 2010, v. 55, n. 8, p. 518, doi. 10.1038/jhg.2010.62
- By:
- Publication type:
- Article
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Serious haematological toxicity during and after ipilimumab treatment: a case series.
- Published in:
- Journal of Medical Case Reports, 2014, v. 8, n. 1, p. 1, doi. 10.1186/1752-1947-8-240
- By:
- Publication type:
- Article
Serious haematological toxicity during and after ipilimumab treatment: a case series.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 6, p. 3694, doi. 10.1245/s10434-021-11236-y
- By:
- Publication type:
- Article
Sentinel lymph node biopsy does not change melanoma-specific survival among patients with breslow thickness greater than four millimeters.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2004, v. 11, p. 198S, doi. 10.1007/BF02523628
- By:
- Publication type:
- Article
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0989-7
- By:
- Publication type:
- Article
Management of cutaneous melanoma: radiologists challenging and risk assessment.
- Published in:
- La Radiologia Medica, 2022, v. 127, n. 8, p. 899, doi. 10.1007/s11547-022-01522-4
- By:
- Publication type:
- Article
Potential clinical implications of CD4<sup>+</sup>CD26<sup>high</sup> T cells for nivolumab treated melanoma patients.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04184-6
- By:
- Publication type:
- Article
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04117-3
- By:
- Publication type:
- Article
The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04100-y
- By:
- Publication type:
- Article
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
- Published in:
- Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03592-4
- By:
- Publication type:
- Article
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021.
- Published in:
- Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03472-x
- By:
- Publication type:
- Article
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021.
- Published in:
- Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03471-y
- By:
- Publication type:
- Article
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report.
- Published in:
- BMC Dermatology, 2014, v. 14, n. 1, p. 15, doi. 10.1186/1471-5945-14-15
- By:
- Publication type:
- Article